Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
250
Trial Sponsor
Clinical Trial Start Date
2008
0Primary Completion Date
2010
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Interventional Trial Phase
Phase 20
Official Name
Phase II Study of Low Intensity Allogeneic Transplantation in Mantle Cell Lymphoma0
Last Updated
August 2, 2013
0Allocation Type
Non-Randomized0
Study summary
RATIONALE: Giving chemotherapy and monoclonal antibody therapy before a donor stem cell transplant helps stop the growth of cancer cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. PURPOSE: This phase II trial is studying donor stem cell transplant in treating patients with mantle cell lymphoma.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
